Publications

The checklist and reference list is meant to complement and build on the most recent normative guidelines produced by UNAIDS Cosponsors and the Secretariat and not to replace them. The checklist has built-in hyperlinks for such guidelines for easy reference. The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). 

The purpose of this document is to provide guidance to national AIDS programmes and partners on the use of indicators to measure and report on the country HIV response.

The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV. 

This report provides a summary of key developments in the legal environment for HIV responses in Asia and the Pacific. It is the product of a desk review conducted for UNAIDS and the United Nations Development Programme (UNDP) in 2019. The report highlights key trends and developments in laws affecting people living with HIV and key populations in Asia and the Pacific over the five-year period 2014–2019.

The current HIV program is reaching KPs and PLHIV for prevention and treatment of HIV. The integrated intervention to KPs and providing HCV related activities like prevention, early diagnosis and providing treatment to cure HCV infection would be the cost-effective approach to decrease the burden of HCV among them. The availability of effective treatment – Direct - Acting Antiviral (DAA) has prevented HCV related consequences and cured from HCV infections. The pangenotypic DAA do not require genotyping of the virus and current WHO guidelines recommends that all HCV infected people are treated with minimal lab investigations and follow up. This recommendation helps us to combat Hep C related complications and prevent morbidities and mortalities and provide opportunity to treat clients at all kind of health facilities.

People who use drugs, especially people who smoke or inject drugs, face additional risks and vulnerabilities to COVID-19 infection compared to the general population. Maintaining services for this population and safeguarding funding for harm reduction is therefore crucial. The pandemic and related responses have affected harm reduction service provision and the lives of people who use drugs worldwide. Understanding the impact of COVID-19 on harm reduction funding and service provision is essential for informing donor and government action as well as civil society advocacy. This report and briefing summarise evidence from civil society in seven Asian countries (Cambodia, India, Indonesia, Nepal, Thailand, the Philippines and Vietnam) and provides recommendations to donors and governments on protecting harm reduction in the COVID-19 era.  

The 2018-2019 Annual Report highlights progress made around the Asia Pacific Region to make the vision of the United Nations Sustainable Development Goals a reality for women and girls. UN Women stands behind women’s equal participation in all aspects of life, focusing on five priority areas: increasing women’s leadership and participation; ending violence against women; engaging women in all aspects of peace and security processes; enhancing women's economic empowerment. The report emphasizes these programming achievements which are made possible from collaboration and cooperation with valued partners and donors all teaming up for gender equality.

The Guidance Note provides an explanation of each one of these components, how they relate to UNFPA’s mandate, and outlines key programming steps that can be taken to advance them. It also provides illustrative examples of applying a HRBA across UNFPA’s three transformative results: zero unmet need for contraception; zero preventable maternal deaths; and zero gender-based violence and harmful practices. 

These guidelines have been developed for healthcare providers on trans-competent healthcare services for transgender patients. We hope these guidelines will give you a better understanding of the experiences trans people face as they navigate their way through accessing health services. It is our hope that these guidelines will increase knowledge about trans-inclusive health services in order to create positive health care experiences for trans people and ensure their right to the highest attainable standard of health. This includes ensuring that healthcare meets the Availability, Accessibility, Acceptability, and Quality (AAAQ) framework set out in international human rights standards.

For those people who are highly drug dependent, with a resulting compromised immune system, COVID-19 presents a serious threat to life regardless of age. Governments, non-governmental (NGOs) and community-based organisations (CBOs) working to support people who use drugs, and other vulnerable and marginalised people in society, have had to react rapidly to the massive increase in COVID-19 transmission across countries and continents. The ten case studies presented here provide a snapshot of the responses of specific organisations and communities who work with people who use drugs and some other marginalised groups around the world.